evitria AG, a global antibody expression service provider, specialized in CHO-based transient expression of recombinant antibodies (including bispecific and fusion antibodies) for research purposes, announces the opening of its new head office in Denmark to better serve the growing demand from Scandinavian enterprises. evitria's Nordic office will be headed by Simon Asbjørn Larsen, PhD as Director, Client Relations.

Dr. Larsen specialized in recombinant antibody technology during his doctoral degree at Aarhus University, Denmark. He has since merged his scientific background with commercial roles within the antibody research field and has focused on accelerating antibody discovery and research with partners at pharmaceutical companies, CROs and research institutions.